New Patient Appointment Accepting Virtual Visits or 214-645-4673
Elizabeth Anne Maher, M.D., Ph.D., is a Professor of Internal Medicine and Neurology and the Theodore H. Strauss Professor in Neuro-Oncology at UT Southwestern Medical Center.
Originally from Nova Scotia, Canada, Dr. Maher is a physician-scientist who earned her medical and doctoral degrees from McGill University in Montreal. She completed an internship and residency in internal medicine at the University of Toronto and then completed a medical oncology fellowship and subspecialty neuro-oncology at the Dana-Farber Cancer Institute and Harvard Medical School in Boston, Massachusetts.
Throughout her career, Dr. Maher has served as both a clinical doctor and a research scientist. She joined the faculty at Harvard Medical School, Dana-Farber Cancer Institute upon completing her clinical training, serving as an Instructor in Internal Medicine (Medical Oncology) for six years. During that time, she also pursued additional postdoctoral research training to combine her scientific focus on brain tumors with patient care for those with glioblastoma and the lower-grade gliomas.
Dr. Maher joined the faculty at UT Southwestern in 2006 as Medical Director of the Neuro-Oncology Program, a role she served in until 2013 when she became Director of Translational Research in Neuro-Oncology. She co-founded the Neuro-Oncology Translational Research Laboratory in the Annette Strauss Center for Neuro-Oncology, where she has pursued an active translational research program in gliomas and held numerous federal, state, and foundation grants. She serves as the Director of the Crystal Charity Ball Center for Pediatric Brain and Neurological Diseases, which has focused on pediatric medulloblastoma and glioma.
As a member of the international investigative team studying and targeting the isocitrate dehydrogenase (IDH) mutations in gliomas, Dr. Maher led multiple clinical trials at UT Southwestern that culminated in approval of the first molecularly targeted therapy for low-grade gliomas. Her innovative and groundbreaking work in partnership with UT Southwestern's imaging scientists led to key breakthroughs in translational neuro-oncology. She has published in journals such as The New England Journal of Medicine, Nature Medicine, Journal of Clinical Oncology, Cancer Cell, Cancer Metabolism, and Neuro-Oncology.
Dr. Maher is an active speaker, both nationally and internationally. She has served continuously on National Institutes of Health grant review committees for over 10 years. She has been a member of the Scientific Program and Education committees for the American Society of Clinical Oncology.
She is a member of several professional societies, including the American Society of Clinical Oncology, the Society of Neuro-Oncology, and the American Association of Cancer Research.
Dr. Maher's passion for brain tumor patients is most evident in her work with the Head for the Cure Foundation and her motivational speaking at numerous events, including the Annual North Texas Head for the Cure 5K race.
Results: 1 Locations
New Patient Appointment Accepting Virtual Visits or 214-645-4673
